Repository logo
 
Publication

Human plasma derived prothrombin complex concentrate (OCTAPLEX), the HFF, EPE: Blood Department experience.

2011Conference object Open access
Simple item page
dc.contributor.authorBarra, A
dc.contributor.authorBarradas, A
dc.contributor.authorCardoso, E
dc.contributor.authorCosta, C
dc.contributor.authorGil, A
dc.contributor.authorRodrigues, T
dc.contributor.authorSilva, A
dc.contributor.authorSimões, A
dc.contributor.authorVenâncio, B
dc.date.accessioned2012-09-20T09:45:17Z
dc.date.available2012-09-20T09:45:17Z
dc.date.issued2011
dc.description.abstractBackground: The HPDPCC was introduced in our clinical practice in 2005, and it has some specific clinical recommendations . We use Octaplex mostly to recert coagulation parameters in patients whose status require their quick conversion, mainly to reverse oral anticoagulation. We initially started using Octaplex in lower doses than the recommended by the drug leaflet, trying to find an optimal dose, aiming to avoid side effects. Aims: Our goals are to share our experience using Octaplex in clinical practice, demonstrating that we can obtain rapid results with minimal dose, without adverse events. Methods: We only included in this study patients who have done Octaplex (1unit – 20ml) and have results of measurement of their International Normalized Ratio (INR) before and after the infusion of prothrombin complex concentrate. The INR was determined using the fully automated hemostasis analyser BCS XP System (Siemens) and the reagent Innovin (Dade Behring). The period of the study was, 2005-2010, and included 87 patients with different diseases. The INR results upper than 10 were counted like 10 because the laboratory doesn’t quantify values higher than this. Results: The patients were 64 men and 23 women, with ages ranged between 18 and 85-years-old, average 66,5-years-old 53 were under treatment with oral anticoagulants (OAC), 22 with liver impairment (1.1), and 12 with other pathologies (OP). The INR before treatment varied from 10 (maximal value) to 1.4 (minimal value), the average values were 6.72 to the patients under OAC, 2.15 to the patients with LI and 3.39 to the patients with OP. After treatment the average values were 2.0 to the OAC 1.84 to the LI and 1.76 to the OP. After treatment the maximal value of the INR was 6.9 and the minimal 0.9. The average number of units used to revert the patients clinical status were for OAC 1.62 (in an average of 1.4 number of intakes), for LI 2 units (1 intake) and for OP 2.75 units (1.42 intakes). We didn’t find any adverse post-administration events. Summary/Conclusions: We found better results in the administration of Octaplex in patients doing OAC, where the 1.62 units (in 1.04 intakes) lowered the INR average from 6.72 to 2.0. The dose used to resolve our clinical cases were much lower than the recommended in the drug leaflet. We didn’t find any adverse events in this dose. The clinical practice feedback suggests a quicker INR conversion comparing to fresh frozen plasma.por
dc.identifier.citationREGIONAL CONGRESS OF THE ISBT, Europe, 21, Lisboa, June 18 - 22, 2011por
dc.identifier.urihttp://hdl.handle.net/10400.10/696
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherInternational Society for Blood Transfusionpor
dc.subjectAnticoagulantespor
dc.subjectHipoprotrombinemiaspor
dc.subjectHypoprothrombinemiaspor
dc.subjectAnticoagulantspor
dc.titleHuman plasma derived prothrombin complex concentrate (OCTAPLEX), the HFF, EPE: Blood Department experience.por
dc.typeconference object
dspace.entity.typePublication
oaire.citation.conferencePlaceLisboapor
oaire.citation.titleREGIONAL CONGRESS OF THE ISBT, Europe, 21por
rcaap.rightsopenAccesspor
rcaap.typeconferenceObjectpor

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Cartaz_Co-infecções_doentes infectados_VHC_população estudada_HPDFF_2o EBMS_2012.pdf
Size:
404.35 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

IMU - Comunicações e Conferências